DuPont Agriculture & Nutrition On Track for Strong 2007

Business Segment Positioned for Double-Digit Growth in 2008 and into Next Decade

DES MOINES, Iowa, Dec. 3 /PRNewswire-FirstCall/ -- DuPont Group Vice

President J. Erik Fyrwald today said that the company's Agriculture &

Nutrition business platform is on track with its previously announced August

financial forecast for the full year 2007, positioning the business for solid

2008 financial performance. Fyrwald's comments came during a business review

series conference call with investment analysts.

"DuPont Agriculture & Nutrition is on track to increase revenue and

earnings by more than 10 percent this year," Fyrwald said. He noted that the

biggest gains are coming from an anticipated 15 percent increase in seed sales

by the Pioneer Hi-Bred business, based on increased global corn acres and

strong results from international operations.

"With our positive momentum in North America and around the world, we are

targeting to generate double-digit earnings growth through the foreseeable

future," Fyrwald said. "Our rich product pipeline will continue to feed that

growth with the release of new technologies each year."

The company is on track to launch Rynaxypyr(TM) insecticide and disease

resistant corn in 2008; Optimum(TM) GAT(TM) soybeans and high oleic soybeans

in 2009, and; Optimum GAT corn in 2010. Other key traits that will follow

include drought tolerance, increased yields and nitrogen use efficiency.

DuPont introduced Accelerated Yield Technology (AYT(TM)) in soybeans in 2007.

Fyrwald outlined the company's plan to continue growing its Agriculture &

Nutrition businesses. In addition to growth from robust research pipelines at

its Crop Protection and Pioneer businesses and majority-owned joint venture

Solae, DuPont expects significant growth gains in Latin America, Europe,

Africa and Asia.

"DuPont has been aggressively establishing businesses and business

relationships in key markets around the world," Fyrwald said. "While we will

grow our business in North America, the fastest growth will come from key

emerging markets like Brazil, India, eastern Europe and China."

DuPont also announced a joint venture with a Chinese biotech research firm

to strengthen its trait discovery research efforts and expand its seed

presence in the Chinese market.

A replay of today's conference call can be found at the Investor Center on

the company's website at

DuPont (NYSE: DD) is a science-based products and services company.

Founded in 1802, DuPont puts science to work by creating sustainable solutions

essential to a better, safer, healthier life for people everywhere. Operating

in more than 70 countries, DuPont offers a wide range of innovative products

and services for markets including agriculture and food; building and

construction; communications; and transportation.

Forward-Looking Statements: This news release contains forward-looking

statements based on management's current expectations, estimates and

projections. All statements that address expectations or projections about

the future, including statements about the company's strategy for growth,

product development, market position, expected expenditures and financial

results are forward-looking statements. Some of the forward-looking

statements may be identified by words like "expects," "anticipates," "plans,"

"intends," "projects," "indicates," and similar expressions. These statements

are not guarantees of future performance and involve a number of risks,

uncertainties and assumptions. Many factors, including those discussed more

fully elsewhere in this release and in DuPont's filings with the Securities

and Exchange Commission, particularly its latest annual report on Form 10-K,

as well as others, could cause results to differ materially from those stated.

These factors include, but are not limited to changes in the laws,

regulations, policies and economic conditions of countries in which the

company does business; competitive pressures; successful integration of

structural changes, including acquisitions, divestitures and alliances;

research and development of new products, including regulatory approval and

market acceptance, and seasonality of sales of agricultural products.